Sheets Smith Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sheets Smith Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,563	Closed	-$384K	–	396
2021 Q4	$384K	Buy	3,563 +4	+0.1%	+$436	0.05%	268
2021 Q3	$390K	Buy	3,559 +20	+0.6%	+$2.08K	0.05%	253
2021 Q2	$331K	Buy	+3,539	New	+$326K	0.04%	285
2019 Q3	–	Sell	-21,766	Closed	-$524K	–	329
2019 Q2	$524K	Sell	21,766 -203	-0.9%	-$5.15K	0.11%	199
2019 Q1	$581K	Buy	21,969 +5,875	+37%	+$139K	0.13%	177
2018 Q4	$314K	Buy	+16,094	New	+$315K	0.08%	221
2015 Q3	–	Sell	-27,715	Closed	-$963K	–	243
2015 Q2	$963K	Buy	+27,715	New	+$846K	0.26%	112

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sheets Smith Wealth Management's HZNP Position: Q1 2022 in Review

Sheets Smith Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2022, closing a stake of 3,563 shares — an estimated $384K sold.

Sheets Smith Wealth Management first reported a position in HZNP in Q2 2015 and held it in 7 quarters. The position peaked at $963K in Q2 2015. 620 funds tracked by Wall St. Rank hold HZNP as of Q1 2022.

Sheets Smith Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Sheets Smith Wealth Management sold 3,563 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2022, an estimated $384K.
Sheets Smith Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 7 quarters.
Sheets Smith Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $963K in Q2 2015.
620 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2022.

Based on Sheets Smith Wealth Management's 13F filing for Q1 2022, filed 2 May 2022.